Fortis Healthcare Limited has announced its unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026. The Board of Directors approved these results, which include detailed financial statements for revenue, expenses, profit, and other comprehensive income. The report also highlights various notes and disclosures pertaining to ongoing investigations and legal matters.
Fortis Healthcare Announces Q2 FY27 Financial Results
Fortis Healthcare Limited has officially released its unaudited standalone and consolidated financial results for the second quarter and the six months ended September 30, 2026. The company’s Board of Directors convened a meeting on November 5, 2026, to consider and approve these financial statements.
Key Financial Highlights
The results provide a comprehensive overview of the company’s financial performance, detailing figures for revenue from operations, other income, and total income. Expenses across various categories such as employee benefits, finance costs, and depreciation are also presented. Net profit and total comprehensive income for both continuing and discontinued operations are reported, along with earnings per share.
The standalone financial results indicate figures for the quarter ended September 30, 2026, as well as comparative periods. Similarly, the consolidated financial results offer a broader view of the group’s performance, incorporating the financial outcomes of its subsidiaries.
Operational and Legal Disclosures
Significant notes accompany the financial results, shedding light on various operational aspects and legal proceedings. These include details on ongoing investigations, exceptional items, and other significant disclosures that provide context to the financial figures. The report also mentions the limited review conducted by the statutory auditors, BSR & Co. LLP, confirming the accuracy and compliance of the presented financial information with relevant regulations.
The financial statements are prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standard 34 “Interim Financial Reporting” and comply with the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Source: BSE
